CHRISTOPHER STELTON, MD
Retina Specialist (Ophthalmology) Physician · SARASOTA, FL
Individual Active NPI 1013234624
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,113 | 1,102,126 | $9,010,289 | $6,649,783 | $5,241,814 |
| 2023 | 2,120 | 257,232 | $7,540,276 | $5,381,708 | $4,223,394 |
| 2022 | 2,029 | 25,260 | $6,428,937 | $4,410,322 | $3,445,385 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 992,960 | $1 | $1 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 91,020 | $35 | $27 |
| 92134 | Imaging of retina | 4,628 | $38 | $30 |
| 67028 | Injection of drug into eye | 2,404 | $117 | $93 |
| 92014 | Established patient complete exam of visual system | 2,064 | $119 | $86 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,860 | $109 | $87 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,672 | $331 | $264 |
| 92012 | Established patient problem focused exam of visual system | 1,660 | $84 | $67 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,140 | $145 | $115 |
| J2778 | Injection, ranibizumab, 0.1 mg | 975 | $163 | $126 |
| J0178 | Injection, aflibercept, 1 mg | 690 | $832 | $654 |
| 92004 | New patient complete exam of visual system | 393 | $141 | $106 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ✓ | ME125837 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Retina Specialist (Ophthalmology) Physician providers in Florida
- NPI 1497076335
- NPI 1518910280
- NPI 1164468211
- NPI 1295495166
- NPI 1912533803
- NPI 1467422659
- NPI 1871775551
- NPI 1194170779
See all Retina Specialist (Ophthalmology) Physician providers in Florida →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.